The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
Abstract
Glucocorticoid-remediable aldosteronism (GRA), an autosomal dominant disorder, is characterized by hypertension with variable hyperaldosteronism and by high levels of the abnormal adrenal steroids 18-oxocortisol and 18-hydroxycortisol, which are all under control of adrenocorticotropic hormone and suppressible by glucocorticoids. These abnormalities could result from ectopic expression of aldosterone synthase, which is normally expressed only in adrenal glomerulosa, in the adrenal fasciculata. Genes encoding aldosterone synthase and steroid 11 beta-hydroxylase (expressed in both adrenal fasciculata and glomerulosa), which are 95% identical and lie on chromosome 8q (refs 7, 10), are therefore candidate genes for GRA. Here we demonstrate complete linkage of GRA in a large kindred to a gene duplication arising from unequal crossing over, fusing the 5' regulatory region of 11 beta-hydroxylase to the coding sequences of aldosterone synthase (maximum lod score 5.23 for complete linkage, odds ratio of 170,000:1). This mutation can account for all the physiological abnormalities of GRA. Our result represents the demonstration of a mutation causing hypertension in otherwise phenotypically normal animals or humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with a tandem duplication event, the two human genes are closely linked, separated by 40 kb, exhibiting similar intron/exon structure, and 90 and 95% identity in the coding and non-coding sequences, respectively (59, 70).”
From Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies (2016) · cites this paper as [70]
In the citing paper
“Although gene conversion events in the CYP11B locus are rare, an unusual gene duplication, caused by unequal crossing over between the CYP11B1 and CYP11B2 genes, results in glucocorticoid-remediable aldosteronism (GRA) (490 -492).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [490]
In the citing paper
“The crossover results in one allele having a third, hybrid CYP11B gene in which the ACTHregulated promoter and the first few exons of CYP11B1 are fused in frame to most of the exons of CYP11B2, resulting in the zona fasciculata expression of a chimeric protein with aldosterone synthase activity (490, 491) (Fig. 12).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [490]
In the citing paper
“They are particularly important in patients in glucocorticoid remediable aldosteronism or with aldosterone-producing adenomas associated with KCNJ5 mutations [261,[264], [265], [266], [267], [268], [269], [270], [271], [272]].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [264]
In the citing paper
“Urinary excretion of aldosterone metabolites is increased (Fig. 6) (115, 124), with the urinary (18OHF+18oxoF)/THAldo ratio further supporting diagnosis (116); the urinary metabolite 18oxoTHF (Fig. 7) is characteristically increased.”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [124]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Gilliland, G., Perrin, S., Blanchard, K., & Bunn, H. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2725 · Cited by 1,454
Hypertension: Pathophysiology, Diagnosis, and Management
White, W. B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460110128039 · Cited by 944
Polymorphic DNA region adjacent to the 5' end of the human insulin gene.
Bell, G. I., Karam, J. H., & Rutter, W. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5759 · Cited by 889
Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH
Simpson, E. R., & Waterman, M. R. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002235 · Cited by 506
Sutherland, D. J., Ruse, J. L., & Laidlaw, J. C. (1966) · PubMed Central · Cited by 467
Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta).
Mornet, É., Dupont, J., Vitek, A., & White, P. C. (1989) · PubMed · Cited by 440
Characterization of Two Genes Encoding Human Steroid 11β-Hydroxylase (P-45011β)
Mornet, E., Dupont, J., Vitek, A., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30030-4 · Cited by 405
Research works printed but not linked: 2
- Sutherland, D. J., Ruse, J. L. & Laidlaw, J. C. Can. med. Assoc. J. 95, 1109–1119 (1966).
- Pickering, G. W. in The Epidemiology of Hypertension (eds Stamler, J., Stamler, R. & Pullman, T. N.) 18–27 (Grune & Stratton, New York, 1967).
Cited by
Items 601–700 of 995
Who should be screened for primary aldosteronism? A comprehensive review of current evidence
Huang, W., Lin, Y., Wu, V., Chen, C., Siddique, S., Chia, Y. C., Tay, J. C., Guruprasad, S., Cheng, H., & Kario, K. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14558 · Cited by 18
High Prevalence of Thyroid Ultrasonographic Abnormalities in Primary Aldosteronism
Armanini, D., Nacamulli, D., Scaroni, C. M., Lumachi, F., Selice, R., Fiore, C., Favia, G., & Mantero, F. (2003) · Endocrine · doi:10.1385/endo:22:2:155 · Cited by 15
Gennari, F. J., Hussain-Khan, S., & Segal, A. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.11.028 · Cited by 15
Carvajal, C. A., Stehr, C. B., González, P. A., Riquelme, E. M., Montero, T., Santos, M. J., Kalergis, A. M., & Fardella, C. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03347044 · Cited by 16
August, P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133197.23478.76 · Cited by 15
Evaluation of Endocrine Function
Guber, H. A., & Farag, A. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00024-5 · Cited by 19
Primordial Prevention of Cardiovascular Disease through Applied Genetics
Williams, R. R., Hopkins, P. N., Stephenson, S., Wu, L., & Hunt, S. C. (1999) · Preventive Medicine · doi:10.1006/pmed.1999.0513 · Cited by 15
Riedl, S., Nguyen, H.-H., Clausmeyer, S., Schulze, E., Waldhauser, F., & Bernhardt, R. (2008) · Hormone Research in Paediatrics · doi:10.1159/000137659 · Cited by 15
Karyotypic abnormalities in benign adrenocortical tumors producing aldosterone
Gordon, R. D., Stowasser, M., Martin, N. J., Epping, A., Conic, S., Klemm, S. A., Tunny, T. J., & Rutherford, J. C. (1993) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(93)90078-z · Cited by 15
Genetic Studies in Familial Aldosteronism Not Suppressible by Dexamethasone
Fallo, F., Veglio, F., Mulatero, P., Sonino, N., Pilon, C., Barzon, L., Trimarchi, F., Boscaro, M., & Benvenga, S. (2000) · International Journal on Disability and Human Development · doi:10.1515/ijdhd.2000.1.3.159 · Cited by 16
The Regulation of the Formation of Glucocorticoids and Mineralocorticoids In Vivo
Lehoux, J., Bernard, H., Ducharme, L., Lefèbvre, A., Shapcott, D. J., Tremblay, A., & Véronneau, S. (1996) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(08)60343-4 · Cited by 14
Pathophysiology, Diagnosis, and Treatment of Mineralocorticoid Disorders
Magill, S. B. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130042 · Cited by 17
Transcriptomics, Epigenetics, and Metabolomics of Primary Aldosteronism
Spyroglou, A., Piaditis, G. P., Kaltsas, G., & Alexandraki, K. (2021) · Cancers · doi:10.3390/cancers13215582 · Cited by 16
Shah, W. A., Jan, A., Khan, M. A., Saeed, M., Rahman, N., Ullah, N., Afridi, M. S., Khuda, F., & Akbar, R. (2023) · Genes · doi:10.3390/genes14061184 · Cited by 17
Genetic disorders in primary aldosteronism—familial and somatic
Funder, J. W. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.020 · Cited by 16
Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism
Prada, E. T. A., Castellano, I., Sušnik, E., Yang, Y., Meyer, L. S., Tetti, M., Beuschlein, F., Reincke, M., & Williams, T. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041124 · Cited by 15
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 35
Pathophysiology of bilateral hyperaldosteronism
Nanba, K., & Rainey, W. E. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000729 · Cited by 16
Clinical Syndromes of Metabolic Alkalosis
Moe, O. W., Alpern, R. J., & Seldin, D. W. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00058-6 · Cited by 14
Mineralocorticoid Hypertension and Hypokalemia
Khosla, N., & Hogan, D. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.10.004 · Cited by 14
Lee, I. S., Kim, S. Y., Jang, H. W., Kim, M. K., Lee, J. H., Lee, Y. H., & Jo, Y. S. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.9.1379 · Cited by 14
Genetics of Hypertension: Lessons Learnt from Mendelian and Polygenic Syndromes
Dominiczak, A. F., Brain, N. J. R., Charchar, F. J., McBride, M., Hanlon, N., & Lee, W. K. (2004) · Clinical and Experimental Hypertension · doi:10.1081/ceh-200031939 · Cited by 14
Reynolds, R. M., Shakerdi, L. A., Sandhu, K., Wallace, E. M., Wood, P. J., & Walker, B. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01922 · Cited by 14
The epithelial sodium channel in hypertension
Warnock, D. G. (1999) · Current Hypertension Reports · doi:10.1007/s11906-999-0013-x · Cited by 14
Avoustin, P., Ribouchon, M. T., Vernet, C., N'Guyen, B., Crouau‐Roy, B., & Pontarotti, P. (1994) · Mammalian Genome · doi:10.1007/bf00292011 · Cited by 14
Rogoff, D., Smolenicka, Z., Bergadá, I., Vallejo, G., Barontini, M., Heinrich, J. J., & Ferrari, P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5329 · Cited by 14
Establishing a diagnosis of primary hyperaldosteronism
Moneva, M. H., & Gómez-Sánchez, C. E. (2001) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200106000-00004 · Cited by 14
Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation
Tetti, M., Gong, S., Veglio, F., Reincke, M., & Williams, T. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.934326 · Cited by 13
Functional categorization of gene regulatory variants that cause Mendelian conditions
Cheng, Y.-H. H., Bohaczuk, S. C., & Stergachis, A. B. (2024) · Human Genetics · doi:10.1007/s00439-023-02639-w · Cited by 16
Segal, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3770-3_3 · Cited by 13
The Renaissance of Primary Aldosteronism: What Has it Taught Us?
Stowasser, M., & Gordon, R. D. (2013) · Heart Lung and Circulation · doi:10.1016/j.hlc.2013.01.006 · Cited by 18
Équilibre potassique, hypokaliémie et hyperkaliémie
Dussol, B. (2010) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2010.03.004 · Cited by 13
Disorders of the adrenal cortex: Genetic and molecular aspects
Pitsava, G., Maria, A. G., & Faucz, F. R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931389 · Cited by 13
Sólyom, J., Rácz, K., Peter, F. W., Homoki, J., Sippell, W. G., & Peter, M. (2001) · International Journal on Disability and Human Development · doi:10.1515/ijdhd.2001.2.1.37 · Cited by 13
Luo, G., Lü, F., Qiao, L., Chen, X., Li, G., & Zhang, Y. (2016) · BioMed Research International · doi:10.1155/2016/4182595 · Cited by 13
How to Escape from Primary Aldosteronism? News and Views on an Adrenal Disorder of Salt Retention
Willenberg, H. S. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-100767 · Cited by 14
Genetic Testing in Endocrinology.
Sousa, S. M. D., Hardy, T., Scott, H. S., & Torpy, D. J. (2018) · Europe PMC (PubMed Central) · Cited by 25
Glodny, B., Kühle, C., Cromme, S., Brockmann, J. G., & Winde, G. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.657 · Cited by 13
Lynch, A. I., Arnett, D. K., Davis, B. R., Boerwinkle, E., Ford, C. E., Eckfeldt, J. H., & Leiendecker-Foster, C. (2007) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2007.00381.x · Cited by 13
Screening for genetic causes of hypertension
Dluhy, R. G. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0023-4 · Cited by 17
Self-citationDisorders of steroid 11β-hydroxylase isozymes
White, P. C., & Pascoe, L. (1992) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(92)90033-w · Cited by 18
Liddle's syndrome: A public health menace?
Warnock, D. G., & Bubien, J. K. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90576-6 · Cited by 13
Aldo is back: recent advances and unresolved controversies in hyperaldosteronism
Auchus, R. J. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200303000-00005 · Cited by 13
Primary Hyperaldosteronism and Other Forms of Mineralocorticoid Hypertension
Parthasarathy, H. K., & MacDonald, T. M. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50070-2 · Cited by 13
Glucocorticoids and Mineralocorticoids
Craigie, E., Mullins, J. J., & Bailey, M. A. (2008) · Wiley eBooks · doi:10.1002/9783527626236.ch1 · Cited by 16
Genetics of Hypertension: From Monogenic Analysis to GETomics
Zappa, M., Golino, M., Verdecchia, P., & Angeli, F. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11050154 · Cited by 21
Qi, Y., Niu, W., Cen, W., Cui, C., Zhuoma, C., Zhuang, L.-P., Cai, D., Li, G., Zhou, W., Hou, S., et al. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002230 · Cited by 12
Familial hyperaldosteronism type 1 and pregnancy: successful treatment with low dose dexamethasone
Sanga, V., Lenzini, L., Seccia, T. M., & Rossi, G. P. (2021) · Blood Pressure · doi:10.1080/08037051.2020.1863771 · Cited by 12
Aldosterone Excess and Resistant Hypertension: Investigation and Treatment
Stowasser, M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0439-7 · Cited by 12
Treatment of primary aldosteronism: Where are we now?
Karagiannis, A. I. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9159-3 · Cited by 13
Martínez‐Aguayo, A., Carvajal, C. A., Campino, C., Marlene Aglony, I., Bolte, L., García, H., & Fardella, C. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.052 · Cited by 12
Inherited Renal Tubulopathies Associated With Metabolic Alkalosis: Effects on Blood Pressure
Ariceta, G., & Rodríguez‐Soriano, J. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.10.002 · Cited by 12
65 YEARS OF THE DOUBLE HELIX: Endocrine tumour syndromes in children and adolescents
Goudie, C., Hannah‐Shmouni, F., Kavak, M., Stratakis, C. A., & Foulkes, W. D. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0160 · Cited by 12
William F. Young (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00016-2 · Cited by 18
Miyama, N., Hasegawa, Y., Suzuki, M., Hida, W., Kazama, I., Hatano, R., Sanada, S., Arata, T., Michimata, M., Sato, A., et al. (2007) · Clinical and Experimental Hypertension · doi:10.1080/10641960601096968 · Cited by 12
Velagaleti, R. S., & O’Donnell, C. J. (2009) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.08.002 · Cited by 12
Genetic information in the diagnosis and treatment of hypertension
Tomaszewski, M., Zimmerli, L., Charchar, F. J., & Dominiczak, A. F. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0070-3 · Cited by 12
Linkage mapping for hypertension susceptibility genes
Kato, N., & Julier, C. (1999) · Current Hypertension Reports · doi:10.1007/s11906-999-0069-7 · Cited by 12
Weinberger, M. H. (2000) · Current Opinion in Cardiology · doi:10.1097/00001573-200007000-00008 · Cited by 12
Primary aldosteronism: a new understanding
Gordon, R. D. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb121951.x · Cited by 13
Genetic basis of cardiovascular disease — the renin-angiotensin-aldosterone system as a paradigm
Padmanabhan, N., Padmanabhan, S., & Connell, J. (2000) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2000.060 · Cited by 12
Overview of aldosterone-related genetic syndromes and recent advances
Zennaro, M., Fernandes-Rosa, F. L., & Boulkroun, S. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000409 · Cited by 12
Who needs to be screened for primary aldosteronism?
Huang, W., Liu, F.-H., Cheng, H., Tsai, Y., Huang, Y., Lai, T., Lin, Y., Wu, V., Kao, H., Hou, C. J., et al. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.08.021 · Cited by 11
Unravelling the Genetic Basis of Primary Aldosteronism
Mourtzi, N., Sertedaki, A., Markou, Α., Piaditis, G. P., & Charmandari, E. (2021) · Nutrients · doi:10.3390/nu13030875 · Cited by 11
Genetic and Potential Autoimmune Triggers of Primary Aldosteronism
Williams, T. A., Mulatero, P., Bidlingmaier, M., Beuschlein, F., & Reincke, M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05643 · Cited by 12
A chimeric CYP11B1/CYP11B2 gene in glucocorticoid‐insuppressible familial hyperaldosteronism
Ise, T., Shimoda, A., Takakuwa, H., Kato, T., Izumiya, Y., Shimizu, K., Suzuki, T., Sasano, H., Yokoyama, H., & KOBAYASHI, K. P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01192.x · Cited by 13
HYBRID GENE OR HYBRID STEROIDS IN THE DETECTION AND SCREENING FOR FAMILIAL HYPERALDOSTERONISM TYPE I
Stowasser, M., Bachmann, A. W., Jonsson, J. R., Tunny, T. J., Klemm, S. A., & Gordon, R. D. (1995) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1995.tb02038.x · Cited by 11
Primary and Secondary Hypertension
Blumenfeld, J. D., Liu, F., & Laragh, J. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10046-6 · Cited by 11
Pheochromocytoma and primary aldosteronism
Young, W. F. (1997) · Cancer treatment and research · doi:10.1007/978-1-4615-6355-6_12 · Cited by 11
Aldosterone synthase gene in patients suffering from hyperaldosteronism
Hampf, M., Widimsky, J., Jr., & Bernhardt, R. (1998) · Endocrine Research · doi:10.3109/07435809809032702 · Cited by 11
Inherited Disorders of Renal Salt Homeostasis
Scholl, U. I., & Lifton, R. P. (2013) · Seldin and Giebisch's The Kidney · doi:10.1016/b978-0-12-381462-3.00036-7 · Cited by 10
Self-citationStölting, G., Vo, K. N. T., Haus, J., & Scholl, U. I. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-01020-6 · Cited by 15
Decoding Monogenic Hypertension: A Review of Rare Hypertension Disorders
Gallegos, F. R., Delahunty, M., Hu, J., Yerigeri, S., Dev, V., Bhatt, G., & Raina, R. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf005 · Cited by 13
Auchus, R. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00008-9 · Cited by 15
Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas
Pitsava, G., Faucz, F. R., Stratakis, C. A., & Hannah‐Shmouni, F. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01735-z · Cited by 12
Genetics of Primary Aldosteronism
Vaidya, A., Hamrahian, A. H., & Auchus, R. J. (2015) · Endocrine Practice · doi:10.4158/ep14512.ra · Cited by 11
Disorders of Potassium Metabolism
Gennari, F. J. (1998) · Springer eBooks · doi:10.1007/978-1-4757-6632-5_4 · Cited by 10
Molecular Mechanisms of Primary Aldosteronism
Tevosian, S. G., Fox, S. C., & Ghayee, H. K. (2019) · Endocrinology and Metabolism · doi:10.3803/enm.2019.34.4.355 · Cited by 11
Blood Pressure Regulation and Pathology
Touyz, R. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405206-2.00014-4 · Cited by 20
Dexamethasone-suppressible hypertension
Stewart, P. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02624-6 · Cited by 10
Deoxycorticosterone, 11 β‐hydroxylase and the adrenal cortex
Spoudeas, H. A., Slater, J. D., Rumsby, G., Honour, J. W., & Brook, C. G. D. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb01782.x · Cited by 12
Adrenal Vein Sampling: An Overview
Magill, S. B. (2001) · The Endocrinologist · doi:10.1097/00019616-200109000-00003 · Cited by 10
Urinary steroid profiling: a powerful method for the diagnosis of abnormal steroidogenesis
Koyama, Y., Homma, K., & Hasegawa, T. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.904199 · Cited by 9
Defects of Adrenal Steroidogenesis
Wajnrajch, M. P., & New, M. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00103-9 · Cited by 13
Billeci, A. M. R., Agnelli, G., & Caso, V. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903386276 · Cited by 10
Genetic Determinants of Myocardial Infarction
Breslow, J. L., & Dammerman, M. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1957-7_7 · Cited by 10
Update on Hypertension Management
Miller, C. A. (1999) · Geriatric Nursing · doi:10.1053/gn.1999.v20.101096001 · Cited by 10
Glucocorticoid-remediable aldosteronism.
Dluhy, R. G., & Williams, G. H. (1996) · PubMed · Cited by 10
Self-citationRenin-angiotensin system genes as candidate genes in cardiovascular diseases
Soubrier, F., & Cambien, F. (1993) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(93)90047-a · Cited by 10
15-Hydroxyprostaglandin Dehydrogenase: Cinderella Meets Prince Serendip
Funder, J. W. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.393 · Cited by 10
Shamim, W., Yousufuddin, M., Francis, D. P., Gualdiero, P., Honour, J. W., Anker, S. D., & Coats, A. J. S. (2001) · Heart · doi:10.1136/heart.86.2.139 · Cited by 10
Jamieson, A., Slutsker, L., Inglis, G. C., Campbell, M., Fraser, R., White, P. C., & Connell, J. (1995) · Endocrine Research · doi:10.3109/07435809509030463 · Cited by 10
GENETICS OF PRIMARY ALDOSTERONISM
Gordon, R. D., Klemm, S. A., Tunny, T. J., & Stowasser, M. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02466.x · Cited by 10
Primary Aldosteronism: New Answers, New Questions
Funder, J. W. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565182 · Cited by 10
Two cases of 17α-hydroxylase/17,20-lyase deficiency caused by the CYP17A1 mutation
Lee, H. I., Kwon, A., Suh, J., Choi, H. S., Song, K., Chae, H. W., & Kim, H.-S. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040184.092 · Cited by 9
Systematic Review of Therapeutic Agents and Long-Term Outcomes of Familial Hyperaldosteronism Type 1
Tan, S. T., Boyle, V., & Elston, M. S. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21054 · Cited by 10
Kamei, S., Kaneto, H., Irie, S., Kinoshita, T., Tanabe, A., Hirukawa, H., Tatsumi, F., Shimoda, M., Kohara, K., Mune, T., et al. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12297 · Cited by 9
Association of the variations in the HSD3β gene with primary aldosteronism
Wu, V., Wu, C., Chang, Y., Young, G., Chen, S.-C., Yang, W., Chen, C., Wang, W.-J., Lin, C., Lin, Y., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328360ef3c · Cited by 9
What Have We Learned from the Genetics of Hypertension?
Luft, F. C. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.015 · Cited by 9
Secondary Hypertension: Mineralocorticoid Excess States
Bravo, E. L. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3053-9.50015-9 · Cited by 9
Metadata
- Authors
- Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Brigham and Women's Hospital (US)
- Veterans Health Administration (US)
- ORCID
- Lifton, Richard P.
- Venue
- Nature
- Published
- 1992-01
- Volume
- 355
- Issue
- 6357
- Pages
- 262-265
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1979069430
- Semantic Scholar
- 48f7453ea9e77a6f893ab90603be6343f5cad138
- Cited by
- 1,158
- References
- 23
- Citations by year
- 2026: 18 · 2025: 10 · 2024: 21 · 2023: 37 · 2022: 29 · 2021: 26 · 2020: 25 · 2019: 24 · 2018: 36 · 2017: 35 · 2016: 30 · 2015: 34 · 2014: 34 · 2013: 36 · 2012: 32
- FWCI
- 30.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- glucocorticoid-remediable aldosteronism, aldosterone synthase, 11β-hydroxylase, fusion genes, gene duplication, unequal crossover, hypertension, hyperaldosteronism, 18-oxocortisol, 18-hydroxycortisol, ACTH, chromosome 8q, genetic linkage, autosomal dominant disorder, adrenal glomerulosa
- MeSH terms
- Base Sequence, Chimera, Crossing Over, Genetic, Cytochrome P-450 Enzyme System, Exons, Female, Humans, Hyperaldosteronism, Hypertension, Introns, Male, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Steroid Hydroxylases, Steroid 11-beta-Hydroxylase, Polymerase Chain Reaction, Cytochrome P-450 CYP11B2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.